{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:18:57Z","timestamp":1793110737556,"version":"4.5.0"},"reference-count":113,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14787210.2026.2700381","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:01:46Z","timestamp":1783321306000},"page":"827-844","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Complicated urinary tract infections: evolving definitions, clinical burden, and treatment landscape amid antimicrobial resistance"],"prefix":"10.1080","volume":"24","author":[{"given":"Kamal A.","family":"Hamed","sequence":"first","affiliation":[{"name":"Basilea Pharmaceutica International Ltd","place":["Allschwil, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah H.","family":"Salama","sequence":"additional","affiliation":[{"name":"University of Connecticut School of Medicine","place":["Farmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Moeck","sequence":"additional","affiliation":[{"name":"Basilea Pharmaceutica International Ltd","place":["Allschwil, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.","family":"Wagenlehner","sequence":"additional","affiliation":[{"name":"Justus-Liebig University Giessen","place":["Giessen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-58-2-201"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310283291808"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf459"},{"key":"e_1_3_4_6_1","unstructured":"Bonkat G Kranz J Cai T et al. EAU guidelines: Edn. presented at the EAU annual Congress London United Kingdom 2026 arnhem. The Netherlands: EAU Guidelines Office; 2026 [cited 2026 Mar 10]. Available from: https:\/\/uroweb.org\/guidelines\/urological-infections."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad332"},{"key":"e_1_3_4_8_1","unstructured":"US Department of Health and Human Services. Food and drug administration center for drug evaluation and research. Uncomplicated urinary tract infections: developing drugs for treatment guidance for industry Silver. Spring MD: US FDA; 2019 Aug [cited 2026 Mar 1]. Available from: https:\/\/www.fda.gov\/media\/129531\/download"},{"key":"e_1_3_4_9_1","unstructured":"US Department of Health and Human Services. Food and drug administration center for drug evaluation and research. Complicated urinary tract infections: developing drugs for treatment guidance for industry Silver. Spring MD: US FDA; 2018 Jun [cited 2026 Mar 1]. Available from: https:\/\/www.fda.gov\/media\/71313\/download"},{"key":"e_1_3_4_10_1","unstructured":"National Institute for Health and Care Excellence. Urinary tract infection (lower): antimicrobial prescribing. 2018 Oct [cited 2026 Mar 1]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng109"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01149-8"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz446"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12694"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab591"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0656-6"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2018.05.006"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.08.022"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914433"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2025.102150"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-015-1722-1"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05842-0"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy418"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2018.11.018"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04979-2"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac307"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/diseases14020058"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11050578"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-025-01846-8"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003277.20"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.1862"},{"key":"e_1_3_4_32_1","volume-title":"Poster presented at IDWeek","author":"Sulham K","year":"2020","unstructured":"Sulham K, Reese J. Health resource utilization in patients with complicated urinary tract infections (cUTI) and antibiotic resistance or treatment failure: a retrospective database analysis. In: Poster presented at IDWeek; 2020 Oct 21\u201325; Virtual meeting."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2021.05.013"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2017.1380395"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad428"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf460"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw396"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00877-9"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmicom.2024.105039"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2024.2412628"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16764"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01676-5"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad561"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195703"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02359-21"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.303"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2023.137"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1086\/650482"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181e6ce8f"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.1878"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1086\/675718"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf461"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1086\/651091"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1304"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504906"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2023.03.020"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.uti-0001-2012"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-020-0362-4"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/543974"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-011-0689-9"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.1992.138"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad010"},{"key":"e_1_3_4_64_1","volume-title":"Poster presented at ASM-ESCMID","author":"McGovern PC","year":"2022","unstructured":"McGovern PC, Moeck G, Dane A. Time to change the complicated urinary tract infection primary endpoint? The problem and a potential solution. In: Poster presented at ASM-ESCMID; Dublin, Ireland; 2022 Oct 4\u20137."},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62220-0"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw378"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0438"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ696"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1121"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens5030052"},{"key":"e_1_3_4_71_1","first-page":"Doc09","article-title":"Asymptomatic bacteriuria in recurrent UTI - to treat or not to treat","volume":"5","author":"Cai T","year":"2017","unstructured":"Cai T, Bartoletti R. Asymptomatic bacteriuria in recurrent UTI - to treat or not to treat. GMS Infect Dis. 2017;5:Doc09.","journal-title":"GMS Infect Dis"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens5010004"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad149"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae169"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211058257"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.361"},{"issue":"2","key":"e_1_3_4_77_1","first-page":"1","article-title":"Antimicrobial stewardship to reduce overtreatment of asymptomatic bacteriuria in critical access hospitals: measuring a quality improvement intervention","volume":"46","author":"Ciarkowski CE","year":"2024","unstructured":"Ciarkowski CE, Imlay HN, Bryson-Cahn C, et al. Antimicrobial stewardship to reduce overtreatment of asymptomatic bacteriuria in critical access hospitals: measuring a quality improvement intervention. Infect Control Hosp Epidemiol. 2024;46(2):1\u20137.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1017\/S146342361800066X"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-084485"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01239-7"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac315"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad009"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci8030040"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf462"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf463"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0214-1"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx139"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz530"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.17034"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304748"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801467"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30554-1"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz181"},{"key":"e_1_3_4_94_1","unstructured":"World Health Organization. WHO bacterial priority pathogens list 2024: bacterial pathogens of public health importance to guide research development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024 May 17 [cited 2026 Mar 9]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"e_1_3_4_95_1","unstructured":"U.S. Food and Drug Administration. FDA approves new treatment for uncomplicated urinary tract infections April 24. 2024 [cited 2026 Jan 13]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-uncomplicated-urinary-tract-infections"},{"key":"e_1_3_4_96_1","unstructured":"U.S. Food and Drug Administration. FDA approves new treatment for uncomplicated urinary tract infections in adult women who have limited or no alternative oral antibiotic treatment options. 2024 Oct 24 [cited 2026 Mar 12]. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-new-treatment-uncomplicated-urinary-tract-infections-adult-women-who-have-limited-or-no"},{"key":"e_1_3_4_97_1","unstructured":"GSK. Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUtis) in female adults and paediatric patients 12 years of age and older. 2025 Mar 25 [cited 2026 Mar 12]. Available from: https:\/\/www.gsk.com\/media\/zlngacq0\/blujepa-global-fda-approval.pdf"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf280"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac396"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae296"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01824-24"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400414"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460913.2025.2460387"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2025.01028"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac704"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105462"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf695.003"},{"key":"e_1_3_4_108_1","unstructured":"Spero Therapeutics. Press release: Spero announces NDA resubmission of tebipenem HBr by GSK to the FDA for the treatment of complicated urinary tract infections including pyelonephritis: globe newswire press release. 2025 Dec 19 [cited 2026 Jan 13]. Available from: https:\/\/s3.amazonaws.com\/b2icontent.irpass.cc\/2748\/rl160626.pdf"},{"key":"e_1_3_4_109_1","unstructured":"U.S. Food and Drug Administration. FDA approves first oral carbapenem therapy for complicated urinary tract infections June 17. 2026 [cited 2026 Jun 29]. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-oral-carbapenem-therapy-complicated-urinary-tract-infections"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00934-22"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00210-25"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf277"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00087-25"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01950-25"},{"key":"e_1_3_4_115_1","unstructured":"Basilea. Press release: basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic August 14. 2025 [cited 2026 Mar 12]. Available from https:\/\/www.globenewswire.com\/news-release\/2025\/08\/14\/3133159\/0\/en\/Basilea-announces-in-licensing-of-a-novel-clinical-phase-3-ready-oral-antibiotic.html?print=1"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2700381","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14787210.2026.2700381","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2700381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:26:00Z","timestamp":1788258360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2026.2700381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14787210.2026.2700381"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2026.2700381","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}